PD1-IL12

N/A

Report date: 2025/02/18 16:45:47

Base Information

Drug NamePD1-IL12
Drug Alias NamePD-1-dependent IL-12
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-12 modulators
TargetsInterleukin-12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBonum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBonum Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A